Active substanceEconazoleEconazole
Similar drugsTo uncover
  • Gino-Pevaril®
    suppositories the vagina. 
  • Ifenek
    solution externally 
    Italfarmaco SpA     Italy
  • Ifenek
    powder externally 
    Italfarmaco SpA     Italy
  • Ifenek
    suppositories the vagina. 
    Italfarmaco SpA     Italy
  • Ifenek
    cream externally 
    Italfarmaco SpA     Italy
  • Ecodax®
    cream externally 
  • Dosage form: & nbspcream for external use
    Composition:
    Composition per 1 g of cream:
    Active substance: econazole nitrate 10.0 mg
    Auxiliary substances: sodium hydroxide 0.9 mg, sodium dihydrogen phosphate dihydrate 3.65 mg, phosphoric acid 0.02 mg, chlorocresol 1.0 mg, cetomacrogol 1000 50.0 mg, cetostearyl alcohol (cetyl alcohol 60%, stearyl alcohol 40% ) 70.0 mg, paraffin soft white 150.0 mg, paraffin liquid 60.0 mg, purified water - sk. demand. up to 1.0 g.
    Description:

    Homogeneous homogeneous cream from white to yellowish-white color, practically odorless.

    Pharmacotherapeutic group:antifungal agent
    ATX: & nbsp

    G.01.A.F.05   Econazole

    Pharmacodynamics:

    Econazole is an imidazole derivative, a broad-spectrum antifungal agent for topical application. It has fungicidal and bactericidal action. It inhibits the synthesis of ergosterol, which regulates the permeability of the cell wall of microorganisms.It is active against dermatophytes, yeast and mold fungi: Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, Candida albicans, Torulopsis, Rhodotorula, Malassezia furfur (Pityrosporum orbiculare), causing pityriasis versicolor, Corynebacterium, Epidermophyton floccosum, Aspergillus, Cladosporium, Scopulariopsis brevicautus and some gram-positive bacteria (Streptococcus , Staphylococci and Nocardia minutissima). Effective against fungi, resistant to treatment with other drugs. With topical application causes death of fungi within 3 days, promotes rapid regression of burning and itching of the skin.

    Pharmacokinetics:With external application, the drug penetrates all layers of the skin and the nail plate. Therapeutic concentrations are created in the horny and other layers of the epidermis, as well as in the dermis. When applied to the skin, systemic absorption is minimal and practically insignificant. Less than 1% of the applied dose is excreted with colic masses - the intestine, and the kidneys.
    Indications:

    Dermatomycosis of the skin of the scalp caused by dermatophytes, yeasts, mold fungi, including - complicated by superinfection Gram-positive bacteria.

    - Erythrazm.

    - Multicolored lichen.

    - Skin infections caused by gram-positive microorganisms.

    Contraindications:Hypersensitivity to econazole and other components that make up the drug. Do not apply the product to areas with damaged skin. Children under 18 years.
    Pregnancy and lactation:

    In pregnancy (I-III trimester) apply only if the intended benefit to the mother exceeds the potential risk to the fetus.

    When prescribing the drug during lactation it is necessary to stop breastfeeding.
    Dosing and Administration:

    Outwardly.

    Adults and children over 18 years: on the affected area of ​​the skin, apply the cream in a thin even layer, and rub until absorbed 2 times a day (morning and evening).

    Duration of application - 2 weeks, in the treatment of highly keratinized skin (stop) - up to 1.5 months.

    Side effects:Individual intolerance to econazole and other components that make up the drug. Possible local reactions in the form of burning, itching, irritation and flushing of the skin, hives, dryness, hypopigmentation, skin atrophy
    Overdose:

    If you accidentally take Ecodax cream inside may be nausea, vomiting, diarrhea.

    Treatment: gastric lavage, ingestion of activated charcoal, symptomatic therapy.

    Interaction:

    No data available.

    Special instructions:

    In patients with eczema, before the start of treatment, anti-extemal therapy should be performed. In the absence of the effect of the therapy in the recommended terms, it is necessary to verify the diagnosis. When the first symptoms of hypersensitivity appear, the drug should be discarded.

    Avoid contact with eyes, mucous membranes, open wounds. In case of any of the side effects of the drug should be discontinue its continued use and consult a doctor.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:

    Cream for external use 1%.

    Packaging:

    10 g or 20 g into an aluminum tube, the neck of which is sealed with a diaphragm made of aluminum and with a screw cap made of polyethylene with a protrusion for perforating the membrane. One tube in a cardboard box with instructions for use.

    10 g or 20 g in a plastic laminated tube, the neck of which is sealed with aluminum foil,laminated polyethylene and with a screw cap made of polypropylene with a projection (or without a protrusion) for perforating the foil. One tube in a cardboard box with instructions for use.

    Storage conditions:

    Store at temperatures not higher than 30 ° C. Do not freeze.

    Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N012445 / 01
    Date of registration:26.09.2011
    The owner of the registration certificate:Unik Pharmaceutical Laboratories Unik Pharmaceutical Laboratories India
    Manufacturer: & nbsp
    Representation: & nbspJohnson & Johnson LLC Johnson & Johnson LLC Russia
    Information update date: & nbsp20.10.2015
    Illustrated instructions
      Instructions
      Up